Prize-based contingency management for the treatment of substance abusers: a meta-analysis

Aim To review randomized controlled trials to assess efficacy of a prize‐based contingency management procedure in reducing substance use (where a drug‐free breath or urine sample provides a chance of winning a prize). Methods A meta‐analysis was conducted on papers published from January 2000 to Fe...

Full description

Saved in:
Bibliographic Details
Published inAddiction (Abingdon, England) Vol. 109; no. 9; pp. 1426 - 1436
Main Authors Benishek, Lois A., Dugosh, Karen L., Kirby, Kim C., Matejkowski, Jason, Clements, Nicolle T., Seymour, Brittany L., Festinger, David S.
Format Journal Article
LanguageEnglish
Published Oxford Blackwell Publishing Ltd 01.09.2014
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aim To review randomized controlled trials to assess efficacy of a prize‐based contingency management procedure in reducing substance use (where a drug‐free breath or urine sample provides a chance of winning a prize). Methods A meta‐analysis was conducted on papers published from January 2000 to February 2013 to determine the effect size of studies comparing prize‐based contingency management to a treatment‐as‐usual control condition (k = 19 studies). Parallel analyses evaluated the efficacy of both short‐ (k = nine studies) and long‐term outcomes (k = six studies) of prize‐based contingency management. Results The average end‐of‐treatment effect size (Cohen's d) was 0.46 [95% confidence interval (CI) = 0.37, 0.54]. This effect size decreased at the short‐term (≤3‐month) post‐intervention follow‐up to 0.33 (95% CI = 0.12, 0.54) and at the 6‐month follow‐up time‐point there was no detectable effect [d = −0.09 (95% CI = −0.28, 0.10)]. Conclusion Adding prize‐based contingency management to behavioral support for substance use disorders can increase short‐term abstinence, but the effect does not appear to persist to 6 months.
Bibliography:ark:/67375/WNG-76J6V328-T
istex:D69293AEBB4469B67738131F6CAF9F97CD551700
National Institute on Drug Abuse - No. R01-DA021621
ArticleID:ADD12589
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0965-2140
1360-0443
DOI:10.1111/add.12589